Nestor Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 43.18 Cr
as on 24-10-2024
- Company Age 49 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 98.66 Cr
as on 24-10-2024
- Satisfied Charges ₹ 156.76 Cr
as on 24-10-2024
- Revenue 30.02%
(FY 2023)
- Profit 27.46%
(FY 2023)
- Ebitda 16.64%
(FY 2023)
- Net Worth 13.27%
(FY 2023)
- Total Assets 0.98%
(FY 2023)
About Nestor Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 43.18 Cr.
The company currently has active open charges totaling ₹98.66 Cr. The company has closed loans amounting to ₹156.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Nestor Pharmaceuticals Limited India are Sanjeev Sharma as CFO and Sonia Sharma as Company Secretary. Rahul Sehgal, Bharat Ram, Bhisham Singh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231DL1975PLC007959
- Company No.
007959
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Oct 1975
- Date of AGM
20 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nestor Pharmaceuticals Limited offer?
Nestor Pharmaceuticals Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, API (Active Pharmaceutical Ingredients).
Who are the key members and board of directors at Nestor Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonia Sharma  | Company Secretary | 01-Aug-2012 | Current |
| Sanjeev Sharma | CFO | 05-Nov-2014 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Sehgal | Director | 01-Mar-2011 | Current |
| Bharat Ram | Director | 14-May-2016 | Current |
| Bhisham Singh | Director | 20-Feb-2023 | Current |
| Bhanu Tiwari | Director | 18-Mar-2019 | Current |
| Adarsh Singh | Director | 25-May-2021 | Current |
Financial Performance and Corporate Structure Insights of Nestor Pharmaceuticals.
Nestor Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.02% increase. The company also saw a substantial improvement in profitability, with a 27.46% increase in profit. The company's net worth Soared by an impressive increase of 13.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nestor Pharmaceuticals?
In 2023, Nestor Pharmaceuticals had a promoter holding of 90.18% and a public holding of 9.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Dec 2021 | ₹2.84 Cr | Open |
Others Creation Date: 09 Dec 2021 | ₹2.15 Cr | Open |
Others Creation Date: 15 Jan 2021 | ₹9.87 Cr | Open |
How Many Employees Work at Nestor Pharmaceuticals?
Nestor Pharmaceuticals has a workforce of 647 employees as of Jun 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nestor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nestor Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
